The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia, Critical and Emergency Care Group
  4. Cochrane Back and Neck Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Common Mental Disorders Group
  10. Cochrane Consumers and Communication Group
  11. Cochrane Cystic Fibrosis and Genetic Disorders Group
  12. Cochrane Dementia and Cognitive Improvement Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Effective Practice and Organisation of Care Group
  16. Cochrane ENT Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group
  21. Cochrane Gynaecology and Fertility Group
  22. Cochrane Haematological Malignancies Group
  23. Cochrane Heart Group
  24. Cochrane Hepato-Biliary Group
  25. Cochrane HIV/AIDS Group
  26. Cochrane Hypertension Group
  27. Cochrane IBD Group
  28. Cochrane Incontinence Group
  29. Cochrane Infectious Diseases Group
  30. Cochrane Injuries Group
  31. Cochrane Kidney and Transplant Group
  32. Cochrane Lung Cancer Group
  33. Cochrane Metabolic and Endocrine Disorders Group
  34. Cochrane Methodology Review Group
  35. Cochrane Movement Disorders Group
  36. Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
  37. Cochrane Musculoskeletal Group
  38. Cochrane Neonatal Group
  39. Cochrane Neuromuscular Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Pregnancy and Childbirth Group
  43. Cochrane Public Health Group
  44. Cochrane Schizophrenia Group
  45. Cochrane Skin Group
  46. Cochrane STI Group
  47. Cochrane Stroke Group
  48. Cochrane Tobacco Addiction Group
  49. Cochrane Upper GI and Pancreatic Diseases Group
    1. About this group
    2. Reviews
      1. Abdominal drainage versus no drainage post-gastrectomy for gastric cancerReview
      2. Acupuncture for functional dyspepsiaReview
      3. Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthroughReview
      4. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitisReview
      5. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescentsReview
      6. Antioxidants for pain in chronic pancreatitisReview
      7. Argon plasma coagulation therapy for acute non-variceal upper gastrointestinal bleedingReview
      8. Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disordersReview
      9. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancerReview
      10. Chemotherapy for advanced gastric cancerReview
      11. Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junctionReview
      12. Chinese herbal medicine for oesophageal cancerReview
      13. Chinese herbal medicines for acute pancreatitisReview
      14. Chinese herbal medicines for induction of remission in advanced or late gastric cancerReview
      15. Cisapride treatment for gastro-oesophageal reflux in childrenReview
      16. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagusReviewWithdrawn
      17. Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleedingReview
      18. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancerReviewDiagnostic
      19. Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancerReviewDiagnostic
      20. Duodenum-preserving pancreatic resection versus pancreaticoduodenectomy for chronic pancreatitisReview
      21. Early routine endoscopic retrograde cholangiopancreatography strategy versus early conservative management strategy in acute gallstone pancreatitisReview
      22. Early versus delayed laparoscopic cholecystectomy for acute gallstone pancreatitisReview
      23. Endoscopic mucosal resection for early gastric cancerReview
      24. Endoscopic or surgical intervention for painful obstructive chronic pancreatitisReview
      25. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasiaReview
      26. Endoscopic retrograde cholangiopancreatography in gallstone-associated acute pancreatitisReviewWithdrawn
      27. Enhanced recovery protocols for major upper gastrointestinal, liver and pancreatic surgeryReview
      28. Enteral nutrition formulations for acute pancreatitisReview
      29. Enteral versus parenteral nutrition for acute pancreatitisReview
      30. Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcersReview
      31. Eradication of Helicobacter pylori for non-ulcer dyspepsiaReviewWithdrawn
      32. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive peopleReview
      33. Extent of lymph node dissection for adenocarcinoma of the stomachReview
      34. Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgeryReview
      35. Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitisReview
      36. Helicobacter pylori eradication for the prevention of gastric neoplasiaReview
      37. Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcerReview
      38. Initial management strategies for dyspepsiaReview
      39. Interventions for dysphagia in oesophageal cancerReview
      40. Interventions for necrotising pancreatitisReviewNew
      41. Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adultsReview
      42. Laparoscopic repair for perforated peptic ulcer diseaseReview
      43. Laparoscopic versus open distal pancreatectomy for pancreatic cancerReviewNew
      44. Laparoscopic versus open gastrectomy for gastric cancerReview
      45. Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancerReview
      46. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesionsReview
      47. Management strategies for pancreatic pseudocystsReviewNew
      48. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux diseaseReviewWithdrawn
      49. Medical treatments in the short term management of reflux oesophagitisReviewWithdrawn
      50. Medical versus surgical treatment for refractory or recurrent peptic ulcerReview
      51. Metoclopramide for post-pyloric placement of naso-enteral feeding tubesReview
      52. Metoclopramide, thickened feedings, and positioning for gastro-oesophageal reflux in children under two yearsReview
      53. Neoadjuvant chemotherapy versus none for resectable gastric cancerReviewWithdrawn
      54. Nitrates for achalasiaReview
      55. Non-surgical interventions for eosinophilic esophagitisReview
      56. Non-surgical versus surgical treatment for oesophageal cancerReview
      57. Omentoplasty for oesophagogastrostomy after oesophagectomyReview
      58. Opioids for acute pancreatitis painReview
      59. Optimum duration of regimens for Helicobacter pylori eradicationReview
      60. Palliative biliary stents for obstructing pancreatic carcinomaReview
      61. Pancreatic enzymes for chronic pancreatitisReview
      62. Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbancesReview
      63. Percutaneous endoscopic gastrostomy versus percutaneous radiological gastrostomy for swallowing disturbancesReview
      64. Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infectionReview
      65. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagusReview
      66. Pharmacological interventions for non-ulcer dyspepsiaReviewWithdrawn
      67. Pharmacological treatment of children with gastro-oesophageal refluxReview
      68. Post-surgical chemotherapy versus surgery alone for resectable gastric cancerReview
      69. Pregabalin for decreasing pancreatic pain in chronic pancreatitisReview
      70. Preoperative chemotherapy for resectable thoracic esophageal cancerReview
      71. Preoperative radiotherapy for esophageal carcinomaReview
      72. Prevention of NSAID-induced gastroduodenal ulcersReview
      73. Prophylactic abdominal drainage for pancreatic surgeryReview
      74. Prophylactic gastrojejunostomy for unresectable periampullary carcinomaReview
      75. Proton pump inhibitor treatment for acute peptic ulcer bleedingReview
      76. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleedingReview
      77. Psychological interventions for non-ulcer dyspepsiaReviewWithdrawn
      78. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinomaReview
      79. Red cell transfusion for the management of upper gastrointestinal haemorrhageReview
      80. Resection versus other treatments for locally advanced pancreatic cancerReview
      81. Screening for oesophageal cancerReview
      82. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux diseaseReview
      83. Somatostatin analogues for pancreatic surgeryReview
      84. Stapler versus scalpel resection followed by hand-sewn closure of the pancreatic remnant for distal pancreatectomyReview
      85. Stents for the prevention of pancreatic fistula following pancreaticoduodenectomyReview
      86. Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagusReview
      87. Surveillance of gastric intestinal metaplasia for the prevention of gastric cancerReview
      88. Tranexamic acid for upper gastrointestinal bleedingReview
      89. Treatment for Barrett's oesophagusReview
    3. Protocols
      1. Adjuvant therapy for resected pancreatic cancerProtocol
      2. Antacids and lifestyle advice for reflux oesophagitis and Endoscopy Negative Reflux DiseaseProtocol
      3. Antecolic versus retrocolic reconstruction for prevention of delayed gastric emptying after partial pancreaticoduodenectomyProtocol
      4. Antidepressants and anxiolytics for functional dyspepsiaProtocol
      5. Antioxidants for acute pancreatitisProtocol
      6. Antiproteases for acute pancreatitisProtocol
      7. Biodegradable anastomotic ring for gastrointestinal anastomosisProtocol
      8. Carbon dioxide detection for diagnosis of inadvertent respiratory tract placement of enterogastric tubes in childrenProtocolDiagnostic
      9. Carbon dioxide detection for testing nasogastric tube placement in adultsProtocolDiagnostic
      10. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancerProtocol
      11. Chemotherapy, radiotherapy, chemoradiotherapy and combination therapy in localised and locally advanced pancreatic cancerProtocol
      12. Chinese herbal medicine alone or combined with vitamins for gastric precancerous lesionsProtocol
      13. Chinese herbal medicine for advanced pancreatic cancerProtocol
      14. Conservative interventions for the management of impacted food bolus in the oesophagusProtocol
      15. Deprescribing versus continuation of chronic proton pump inhibitor use in adultsProtocol
      16. Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancerProtocolDiagnostic
      17. Electrosurgical current for endoscopic biliary sphincterotomy (EBS) for the prevention of post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitisProtocol
      18. Endoscopic drainage with or without endo-ultrasonography for pancreatic pseudocystProtocol
      19. Endoscopic intervention for the prevention of post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitisProtocolWithdrawn
      20. Eradication of Helicobacter pylori for iron deficiencyProtocol
      21. Erlotinib for advanced pancreatic cancerProtocol
      22. Erythromycin and related macrolides for gastroparesisProtocolNew
      23. Extended lymph node resection versus standard resection for pancreatic and peri-ampullary adenocarcinomaProtocol
      24. Fasting for haemostasis in children with gastrointestinal bleedingProtocol
      25. Helicobacter pylori eradication for premalignant lesions of the gastric mucosaProtocol
      26. High dose versus standard dose proton pump inhibitor for short term management of erosive reflux oesophagitisProtocol
      27. Imaging modalities for characterising focal pancreatic lesionsProtocolDiagnostic
      28. Imatinib mesylate for gastrointestinal stromal tumours (GISTs)ProtocolWithdrawn
      29. Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care unitsProtocol
      30. Interventions for the management of esophageal candidiasis in immunocompromised patientsProtocol
      31. Intraperitoneal chemotherapy for gastric carcinomaProtocol
      32. Laparoscopic cardiomyotomy versus endoscopic pneumatic dilation for primary achalasiaProtocol
      33. Laparoscopic fundoplication for gastro-oesophageal reflux disease (GORD) in adultsProtocol
      34. Lexipafant for acute pancreatitisProtocol
      35. Mesh reinforcement versus primary repair in laparoscopic paraoesophageal hernia repairs of the hiatusProtocol
      36. Minimal access drainage procedures for patients with necrotising pancreatitisProtocol
      37. Molecular-targeted therapy for advanced gastric cancerProtocol
      38. Nasogastric versus nasojejunal tube feeding for severe acute pancreatitisProtocol
      39. Non-invasive diagnostic tests for Helicobacter pylori infectionProtocolDiagnostic
      40. Nonsteroidal anti-inflammatories (NSAIDs) and aspirin for intestinal metaplasia of the stomachProtocol
      41. Optimum antibiotic doses for Helicobacter pylori eradicationProtocol
      42. Optimum second-line regimens for Helicobacter pylori eradicationProtocol
      43. Pancreatic amylase in drain fluid for the diagnosis of pancreatic leak in post pancreatic resectionProtocolDiagnostic
      44. Pancreatic duct guidewire placement for biliary cannulation for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP)Protocol
      45. Perioperative corticosteroids for reducing postoperative complications following esophagectomyProtocol
      46. Pharmacologic and radiotherapeutic interventions for advanced pancreatic cancerProtocol
      47. Pharmacological interventions for acute pancreatitis: a network meta-analysisProtocol
      48. Postoperative chemotherapy or radiotherapy for esophageal cancerProtocol
      49. Preoperative radiotherapy chemotherapy and surgery versus surgery alone for esophageal cancerProtocol
      50. Probiotics as adjunctive therapy for eradication of Helicobacter pylori infectionProtocol
      51. Prokinetics for functional dyspepsiaProtocol
      52. Proton pump inhibitor-based triple therapies versus dual therapies for Helicobacter pylori eradicationProtocol
      53. Proton pump inhibitor versus placebo in the short term management of gastro-esophageal reflux diseaseProtocol
      54. Proton pump inhibitors for functional dyspepsiaProtocol
      55. Routine cholecystectomy during Roux-en-Y gastric bypass with or without choledocholithiasisProtocol
      56. Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinomaProtocol
      57. Sequential versus standard triple therapy for Helicobacter pylori eradicationProtocol
      58. Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis and serum C-reactive protein, procalcitonin and lactate dehydrogenase for the diagnosis of pancreatic necrosisProtocolDiagnostic
      59. Somatostatin analogues for carcinoid syndromeProtocol
      60. Somatostatin or somatostatin analogues for acute non-variceal upper gastrointestinal bleedingProtocol
      61. Total pancreatectomy and islet autotransplantation for chronic pancreatitisProtocol
      62. Ultrasonography for confirmation of gastric tube placementProtocolDiagnostic
  50. Cochrane Urology Group
  51. Cochrane Vascular Group
  52. Cochrane Work Group
  53. Cochrane Wounds Group

SEARCH